The Food and Drug Administration Modernization Act of 1997 (FDAMA) added the “De Novo” classification option as an alternate pathway to classify certain new devices that had automatically been placed in Class III due to lack of a predicate.

Go here to read the rest:
Evaluation of Automatic Class III Designation (De Novo) Decision Summaries: K102333 added